Plasma Cell but Not CD20-Mediated B Cell Depletion Protects from Bleomycin-Induced Lung Fibrosis

To determine the therapeutic potential of inhibiting B cell function in pulmonary fibrosis, scientists examined the effects of anti-CD20 B cell ablation therapy to selectively remove mature B-cells from the immune system and inhibit Blm-induced lung fibrosis.
[European Respiratory Journal]

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News